Timing matters in the use of renin-angiotensin system modulators and COVID-related cognitive and cerebrovascular dysfunction.

PLoS One · 2024 · PMC11285960 · PMID 39074114

Europe PMC DOI

hedged sentence

0.0520

closest p · 1.0× alpha

0.0520

boldest claim

The sentences

marginally non-significantP = 0.052so close (0.05 < p ≤ 0.1)

Our results showed that pre-Losartan treatment caused a reduction in the cerebral blood flow, which was significant compared to the control (*P<0.05), and marginally non-significant compared to the spike protein group (P = 0.052).

also in 274 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.